Hi-Tech Pharmacal (NASDAQ:HITK)

GeoProfile
Overview
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders

Do you represent this company?

Learn how we can help increase your exposure to investors.

Thursday, July 7, 2011, 9:33AM
Hi-Tech Pharmacal (NASDAQ:HITK) crushes estimates. Reports non-gaap EPS of $1.08 estimate was $0.71

Thursday, December 9, 2010, 9:30AM
Hi-Tech Pharmacal (NASDAQ:HITK) Reports fiscal second quarter EPS of $0.76 vs. estimate of $0.56. $$

Monday, March 15, 2010, 9:50AM
Hi-Tech Pharmacal (NASDAQ:HITK) Trade not working out. Foiled by news of equity offering that would result in 30% dilution. Unwinding trade.

Thursday, March 11, 2010, 9:29AM
Hi-Tech Pharmacal (NASDAQ:HITK) crushed estimates again; Beat EPS estimate by $0.17; reports 4th qtr EPS of $0.67; will initiate trade.

Tuesday, March 2, 2010, 9:09AM
Hi-Tech Pharmacal (NASDAQ:HITK) makes accretive acquisition.

Thursday, January 7, 2010, 9:25AM
Hi-Tech Pharmacal (NASDAQ:HITK) ECR Subsidiary to Launch a New Dermatitis Treatment

Wednesday, December 9, 2009, 9:32AM
Hi-Tech Pharmacal (NASDAQ:HITK) reports sharply higher earnings.

Tuesday, July 14, 2009, 9:10AM
Hi-Tech Pharmacal (NASDAQ:HITK) Reports strong fourth quarter. Easily exceeds analyst estimates.